Glenmark Pharmaceuticals Ltd on Friday (February 14) reported a net profit of ₹347.9 crore for Q3FY25, recovering from a net loss of ₹351.3 crore.CompanyValueChange%ChangeRevenue...
Glenmark Pharmaceuticals on Wednesday, February 12, said its US-based subsidiary launched Clindamycin Phosphate Foam, which is used for the treatment of acne.CompanyValueChange%ChangeThis new product...
Glenmark Pharmaceuticals Ltd, in collaboration with Cosmo Pharmaceuticals N.V., has received approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) to market...
Drug firm Glenmark Pharmaceuticals Ltd on Friday (February 7) said it has received an order from the Joint Commissioner of Central Goods and Services...